GE Healthcare Technologies, Inc. (GEHC)
70.23
+0.47
(+0.67%)
USD |
NASDAQ |
Oct 20, 16:00
69.85
-0.38
(-0.54%)
Pre-Market: 08:15
GE Healthcare Technologies Research and Development Expense (TTM) : 1.283B for June 30, 2026
Research and Development Expense (TTM) Chart
Historical Research and Development Expense (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | 1.283B |
| March 31, 2026 | 1.262B |
| December 31, 2025 | 1.261B |
| September 30, 2025 | 1.282B |
| June 30, 2025 | 1.306B |
| March 31, 2025 | 1.331B |
| December 31, 2024 | 1.311B |
| September 30, 2024 | 1.282B |
| Date | Value |
|---|---|
| June 30, 2024 | 1.288B |
| March 31, 2024 | 1.259B |
| December 31, 2023 | 1.205B |
| September 30, 2023 | 1.161B |
| June 30, 2023 | 1.099B |
| March 31, 2023 | 1.058B |
| December 31, 2022 | 1.026B |
| September 30, 2022 | 980.00M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (TTM) Benchmarks
| Butterfly Network, Inc. | 38.10M |
| Abbott Laboratories | 3.128B |
| Boston Scientific Corp. | 2.153B |
| Intuitive Surgical, Inc. | -- |
| Stryker Corp. | 1.606B |